deferoxamine has been researched along with Complications, Hematologic Pregnancy in 17 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
Excerpt | Relevance | Reference |
---|---|---|
"In this retrospective cohort study, we described the evolution and outcome of 9 pregnancies in Italian thalassemic women who received deferoxamine (DFO) inadvertently during early pregnancy." | 7.96 | Use of deferoxamine (DFO) in transfusion-dependent β-thalassemia during pregnancy: A retrospective study. ( Brunelli, R; Capone, C; D'Ambrosio, V; Del Negro, V; Giancotti, A; Piccioni, MG; Schiavi, MC; Smacchia, MP; Vena, F, 2020) |
"In our study, chelation treatment during pregnancy did not prevent the delivery of healthy children." | 5.43 | Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic? ( Agapidou, A; Diamantidis, MD; Fotiou, P; Manafas, A; Neokleous, N; Vetsiou, E; Vlachaki, E, 2016) |
"In this retrospective cohort study, we described the evolution and outcome of 9 pregnancies in Italian thalassemic women who received deferoxamine (DFO) inadvertently during early pregnancy." | 3.96 | Use of deferoxamine (DFO) in transfusion-dependent β-thalassemia during pregnancy: A retrospective study. ( Brunelli, R; Capone, C; D'Ambrosio, V; Del Negro, V; Giancotti, A; Piccioni, MG; Schiavi, MC; Smacchia, MP; Vena, F, 2020) |
"In our study, chelation treatment during pregnancy did not prevent the delivery of healthy children." | 1.43 | Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic? ( Agapidou, A; Diamantidis, MD; Fotiou, P; Manafas, A; Neokleous, N; Vetsiou, E; Vlachaki, E, 2016) |
"Deferoxamine therapy was continued throughout 2 pregnancies, while in the other it was stopped after 8 weeks: no abnormalities were noted in the children." | 1.31 | High-risk pregnancy in beta-thalassemia major women. Report of three cases. ( De Marzi, CA; Magliari, F; Perniola, R; Rosatelli, MC, 2000) |
"The twin-pregnancy was complicated by preeclampsia." | 1.30 | Pregnancy and lactation in homozygous beta-thalassemia major. ( Glanzmann, R; Holzgreve, W; Nars, PW; Surbek, DV, 1998) |
"Pregnancy was well tolerated by the heart in all women and no endocrinological disorders were observed." | 1.30 | Fertility in thalassemia: the Greek experience. ( Karagiorga-Lagana, M, 1998) |
"Successful pregnancy is described in a patient with beta-thalassaemia major, transfusion-dependent from four months of age and treated with desferrioxamine from 13 years of age." | 1.27 | Successful pregnancy in beta-thalassaemia major. ( Martin, K, 1983) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (29.41) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Piccioni, MG | 1 |
Capone, C | 1 |
Vena, F | 1 |
Del Negro, V | 1 |
Schiavi, MC | 1 |
D'Ambrosio, V | 1 |
Giancotti, A | 1 |
Smacchia, MP | 1 |
Brunelli, R | 1 |
Diamantidis, MD | 1 |
Neokleous, N | 1 |
Agapidou, A | 1 |
Vetsiou, E | 1 |
Manafas, A | 1 |
Fotiou, P | 1 |
Vlachaki, E | 1 |
Shetty, A | 1 |
Anwar, SQ | 1 |
Acharya, S | 1 |
Sözen, M | 1 |
Karaaslan, C | 1 |
Oner, R | 1 |
Gümrük, F | 1 |
Ozdemir, MA | 1 |
Altay, C | 1 |
Gürgey, A | 1 |
Oner, C | 1 |
Beneitez, D | 1 |
Casellas, M | 1 |
Carrera, A | 1 |
Duran-Suárez, JR | 1 |
Martin, K | 1 |
Meadows, K | 1 |
Dolfin, G | 1 |
Lumare, A | 1 |
Tinetti, E | 1 |
Monetti, C | 1 |
Jacob, R | 1 |
Martoglio, G | 1 |
Thomas, RM | 1 |
Skalicka, AE | 1 |
Fistarol, M | 1 |
Zardini, E | 1 |
Surbek, DV | 1 |
Glanzmann, R | 1 |
Nars, PW | 1 |
Holzgreve, W | 1 |
Singer, ST | 1 |
Vichinsky, EP | 1 |
Karagiorga-Lagana, M | 1 |
Perniola, R | 1 |
Magliari, F | 1 |
Rosatelli, MC | 1 |
De Marzi, CA | 1 |
Pafumi, C | 1 |
Zizza, G | 1 |
Caruso, S | 1 |
Todaro, AM | 1 |
Pernicone, G | 1 |
Bandiera, S | 1 |
Farina, M | 1 |
Russo, A | 1 |
Palagiano, A | 1 |
Pace, L | 1 |
Stacher, A | 1 |
1 review available for deferoxamine and Complications, Hematologic Pregnancy
Article | Year |
---|---|
[Diseases caused by iron metabolism disorders and their therapy].
Topics: Adult; Anemia, Hypochromic; Anti-Glomerular Basement Membrane Disease; Bloodletting; Deferoxamine; D | 1969 |
16 other studies available for deferoxamine and Complications, Hematologic Pregnancy
Article | Year |
---|---|
Use of deferoxamine (DFO) in transfusion-dependent β-thalassemia during pregnancy: A retrospective study.
Topics: Adult; beta-Thalassemia; Chelation Therapy; Deferoxamine; Female; Humans; Live Birth; Maternal Expos | 2020 |
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: is deferasirox toxic?
Topics: Adult; Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Femal | 2016 |
Aplastic anaemia in pregnancy.
Topics: Anemia, Aplastic; Combined Modality Therapy; Deferoxamine; Female; Humans; Platelet Transfusion; Pre | 2011 |
Severe hemolytic anemia associated with Hb Volga [beta27(B9)Ala-->Asp]: GCC-->GAC at codon 27 in a Turkish family.
Topics: Adult; Anemia, Hemolytic, Congenital; Blood Protein Electrophoresis; Child, Preschool; Codon; Combin | 2004 |
[Beta-thalassemia major and pregnancy to term].
Topics: Adult; beta-Thalassemia; Deferoxamine; Female; Follow-Up Studies; Humans; Pregnancy; Pregnancy Compl | 2008 |
Successful pregnancy in beta-thalassaemia major.
Topics: Adult; Blood Transfusion; Deferoxamine; Female; Glucose; Humans; Hypoglycemia; Infant, Newborn; Infa | 1983 |
A successful pregnancy outcome in transfusion dependent thalassaemia major.
Topics: Adult; Blood Transfusion; Deferoxamine; Erythrocyte Transfusion; Female; Humans; Infant, Newborn; Ma | 1984 |
[Obstetrical and hematological problems in a pregnant woman with intermediate beta-thalassemia].
Topics: Adult; Blood Transfusion; Deferoxamine; Female; Humans; Pregnancy; Pregnancy Complications, Hematolo | 1983 |
Successful pregnancy in transfusion-dependent thalassaemia.
Topics: Adult; Blood Transfusion; Deferoxamine; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Compli | 1980 |
[Beta-thalassemia and pregnancy: 2 rare cases].
Topics: beta-Thalassemia; Bone Marrow Transplantation; Cardiotocography; Cesarean Section; Combined Modality | 1996 |
Pregnancy and lactation in homozygous beta-thalassemia major.
Topics: Adult; beta-Thalassemia; Breast Feeding; Chelating Agents; Deferoxamine; Female; Homozygote; Humans; | 1998 |
Deferoxamine treatment during pregnancy: is it harmful?
Topics: Abnormalities, Drug-Induced; Adult; Chelating Agents; Deferoxamine; Female; Humans; Pregnancy; Pregn | 1999 |
Fertility in thalassemia: the Greek experience.
Topics: Adult; beta-Thalassemia; Cesarean Section; Chelating Agents; Deferoxamine; Endocrine Glands; Female; | 1998 |
High-risk pregnancy in beta-thalassemia major women. Report of three cases.
Topics: Adult; Aspirin; beta-Thalassemia; Cardiomyopathy, Dilated; Deferoxamine; Female; Humans; Pregnancy; | 2000 |
Pregnancy outcome of a transfusion-dependent thalassemic woman.
Topics: Blood Transfusion; Chelating Agents; Deferoxamine; Female; Ferritins; Humans; Pregnancy; Pregnancy C | 2000 |
[Pregnancy in women with thalassaemia].
Topics: Adult; Blood Transfusion; Chelating Agents; Deferoxamine; Female; Folic Acid; Hematinics; Humans; In | 2001 |